2014•Cancer Chemotherapy and PharmacologyRequires access

A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy

Tsuyoshi Shirakawa, Ken Kato, Kengo Nagashima, Akiko Nishikawa, Ryoichi Sawada, Naoki Takahashi, Hirokazu Shoji, Yusuke Sasaki, Yoshitaka Honma, Satoru Iwasa, Atsuo Takashima, Natsuko Okita, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada

Open publisher page 31 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Docetaxel, Paclitaxel, Medicine, Chemotherapy, Oncology, Internal medicine, Esophageal squamous cell carcinoma, Retrospective cohort study